Author:
Neil James C.,Gilroy Kathryn,Borland Gillian,Hay Jodie,Terry Anne,Kilbey Anna
Reference95 articles.
1. Bauer, O., Sharir, A., Kimura, A., Hantisteanu, S., Takeda, S., & Groner, Y. (2015). Loss of osteoblast Runx3 produces severe congenital osteopenia. Molecular and Cellular Biology, 35, 1097–1109.
2. Ben-Ami, O., Friedman, D., Leshkowitz, D., Goldenberg, D., Orlovsky, K., Pencovich, N., et al. (2013). Addiction of t(8;21) and inv(16) acute myeloid leukemia to native RUNX1. Cell Reports, 4, 1131–1143.
3. Bledsoe, K. L., McGee-Lawrence, M. E., Camilleri, E. T., Wang, X., Riester, S. M., van Wijnen, A. J., et al. (2014). RUNX3 facilitates growth of Ewing sarcoma cells. Journal of Cellular Physiology, 229, 2049–2056.
4. Blyth, K., Terry, A., O’Hara, M., Baxter, E. W., Campbell, M., Stewart, M., et al. (1995). Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: Contrasting effects of homozygous and heterozygous p53 loss. Oncogene, 10, 1717–1723.
5. Blyth, K., Terry, A., Mackay, N., Vaillant, F., Bell, M., Cameron, E. R., et al. (2001). Runx2: A novel oncogenic effector revealed by in vivo complementation and retroviral tagging. Oncogene, 20, 295–302.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献